Bio-Path Holdings Inc (BPTH)
2.14
-0.20
(-8.55%)
USD |
NASDAQ |
May 17, 16:00
2.15
+0.01
(+0.47%)
Pre-Market: 20:00
Bio-Path Holdings Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2018 | -0.017M |
| September 30, 2018 | -0.017M |
| June 30, 2018 | -0.017M |
| March 31, 2018 | -0.131M |
| December 31, 2017 | -0.538M |
| September 30, 2017 | -0.851M |
| June 30, 2017 | -0.876M |
| March 31, 2017 | -0.762M |
| December 31, 2016 | -0.338M |
| September 30, 2016 | -0.025M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.025M |
| Date | Value |
|---|---|
| September 30, 2012 | -0.1325M |
| June 30, 2012 | -0.1575M |
| March 31, 2012 | -0.1626M |
| December 31, 2011 | -0.1701M |
| September 30, 2011 | -0.1168M |
| June 30, 2011 | -0.175M |
| March 31, 2011 | -0.2371M |
| December 31, 2010 | -0.2297M |
| September 30, 2010 | -0.2504M |
| June 30, 2010 | -0.1772M |
| March 31, 2010 | -0.135M |
| December 31, 2009 | -0.11M |
| September 30, 2009 | -0.16M |
| June 30, 2009 | -0.175M |
| March 31, 2009 | -0.15M |
| December 31, 2008 | -0.15M |
| September 30, 2008 | -0.0346M |
| June 30, 2008 | -0.0253M |
| March 31, 2008 | -0.0253M |
| December 31, 2007 | 0.1374M |
| September 30, 2007 | 0.1471M |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| INVO Bioscience Inc | -2.495M |
| Perspective Therapeutics Inc | -48.19M |
| EyePoint Pharmaceuticals Inc | -14.60M |
| Palatin Technologies Inc | 9.41M |
| Lumos Pharma Inc | 10.74M |